News | CT Angiography (CTA) | October 30, 2020

Lung Scans for Stroke Patients Could Provide Earlier COVID-19 Detection

Evaluation of the lung apices using computed tomography angiography of the head and neck during acute ischemic stroke (AIS) can provide the first objective opportunity to screen for coronavirus disease 2019 (COVID-19)

Evaluation of the lung apices using computed tomography angiography of the head and neck during acute ischemic stroke (AIS) can provide the first objective opportunity to screen for coronavirus disease 2019 (COVID-19)

Image courtesy of the American Heart Association

October 30, 2020 — Computed tomography angiogram (CTA) scans may offer fast and early detection of COVID-19 in acute ischemic stroke (AIS) patients, according to new research published in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.

The study, titled "The Utility of Apical Lung Assessment on CTA as a COVID-19 Screen in Acute Stroke," found that in addition to patient-reported COVID-19 symptoms, routine or standard care CTA scans were an accurate screening method for faster detection of COVID-19 since they include imaging of the upper portion of the lungs.

Researchers conducted a retrospective analysis of patients treated for AIS at three hospitals in the Bronx from March 1 to April 30, 2020, the height of the COVID-19 surge in New York City. A total of 57 patients who received a CTA scan within 24 hours of hospitalization for AIS were included in the study. Researchers used CTA scans to evaluate the lung apices (the upper area of the lungs) for signs of COVID-19 pneumonia. They then analyzed the accuracy of using CTA scans for COVID-19 diagnosis alone as well as in combination with patient-reported symptoms, such as cough and/or shortness of breath.

"Every second counts when treating a person experiencing a stroke," said Charles Esenwa, M.D., M.S., lead author of the study, an assistant professor and a stroke neurologist at the Albert Einstein College of Medicine in the Bronx, New York City. "Conducting a CTA is already part of the stroke management process, and these scans provide an opportunity to assess the lungs for signs suggestive of COVID-19. Our team sought to determine if this already necessary scan could have a secondary use of identifying potential COVID-19 patients more quickly than a standard nasal swab COVID-19 test."

The study defined confirmed COVID-19 positive cases from nasal swab PCR-test results, which are the standard required by the U.S. Food and Drug Administration (FDA) for COVID-19 testing, and it can take several days for results. Of the 57 study participants, three were diagnosed with COVID-19 prior to the date when a nasal swab COVID-19 test was administered.

Researchers found that:

  • CTA scans in combination with patient feedback to COVID-19 symptom questions were able to diagnose COVID-19 with 83% accuracy before results were received from traditional nasal swab tests in AIS patients.
  • 30 of the 57 patients included in the study were COVID-19 positive.
  • 20 of the COVID-19 positive patients and 2 of the COVID-19 negative patients had findings highly suspicious for COVID-19 pneumonia on their CTA lung scans.

"In combination with symptoms, CTA scan analysis is relatively accurate in diagnosing COVID-19, even compared to the nasal swab test. Since this analysis is much faster and at no extra cost, we hope it could be incorporated as a rapid diagnosis tool for patients with acute stroke," Esenwa said. "In addition, accurately diagnosing COVID-19 within hours, rather than the sometimes days wait-time to receive the results from nasal swab tests could help protect both patients and medical professionals."

While these findings are promising, the study had some limitations. As there is no universally defined standard for diagnosing COVID-19, the study confirmed infection positivity through the nasal swab COVID-19 test (RT-PCR). Patients who did not have the RT-PCR test performed were excluded from the study. Additionally, diagnostic accuracy may have been higher because the study participants were in an area with higher geographic incidence of COVID-19, which may not be the case in an area with a lower rate of COVID-19 infections.

"Screening questionnaires alone are often inaccurate because of the absence of symptoms or the patient is unable to speak because they are suffering from an acute stroke," Esenwa said. "Early diagnosis via CT scans has helped our center protect other patients and staff through early isolation, and it has also allowed us to start early supportive care for those suspected of having stroke who are COVID-19 positive," Esenwa added.

For more information: www.heart.org

Related Content

A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade reports that the rate of coronary computed tomography angiography (cCTA) exams by radiologists in hospital outpatient departments increased markedly from 2010 to 2019, suggesting a bright future for the technology.

Getty Images

News | Cardiac Imaging | September 28, 2021
September 28, 2021 — A new study published in ...
The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 billion in 2021 at a compound annual growth rate (CAGR) of 7.5%

Varian's Ethos artificial intelligence radiotherapy device.

News | Radiation Oncology | September 28, 2021
September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848
September 28, 2021 — A computer program trained to see patterns among thousands of breast ultrasound images can aid physicians in accurately diagnosing breast cancer, a new study shows.

Breast ultrasound images show cancer (at left, as dark spot in center and, at right, in red, as highlighted by a computer). Image courtesy of Nature Communications

News | Breast Imaging | September 28, 2021
September 28, 2021 — A computer program trained to see patterns among thousands of...
GE Healthcare's Definium Tempo Fixed X-ray System (Photo: Business Wire)

GE Healthcare's Definium Tempo Fixed X-ray System (Photo: Business Wire)

News | Digital Radiography (DR) | September 28, 2021
September 28, 2021 — GE Healthcare introduced the Definium Tempo, a new fixed, overhead tube suspension (OTS)...
GE Healthcare unveiled Revolution Ascend with Effortless Workflow, offering clinicians a collection of artificial intelligence technologies that automate and simplify time-consuming tasks to increase operational efficiency and free up time for clinicians to deliver more personalized care to more patients.
News | Computed Tomography (CT) | September 27, 2021
September 27, 2021 — GE Heal
Esaote, an Italian company leader in the biomedical equipment sector – ultrasound, MRI and software for the medical sector – launched E-shop: the new online store to reach medical professionals more quickly and effectively.
News | Radiology Business | September 27, 2021
September 27, 2021 — Esaote, an Italian company leader in the biomedical equipment sector –...
Zebra Medical Vision now offers artificial intelligence (A) medical imaging analytics for its cardiac solution HealthCCSng, which enables the quantification of the coronary artery calcium (CAC) on CT scans as an incidental finding.
News | Artificial Intelligence | September 27, 2021
September 27, 2021 — Zebra Medical Vision, the deep-learning medical imaging analytics company, announces its eighth

Image courtesy of Ziehm

News | Mobile C-Arms | September 27, 2021
September 27, 2021 — According to the statistics by the World Health O...
Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.

Getty Images

News | Prostate Cancer | September 24, 2021
September 24, 2021 — Scientists have identified two subtypes of metastatic...